Former Ardent Health exec plans sale of 35,930 shares

Ardent Health, Inc. (ARDT) is the issuer for a planned resale of common stock under Rule 144 by former officer and director Martin Bonick.

Rhea-AI Filing Summary

Ardent Health, Inc. (ARDT) is the issuer for a planned resale of common stock under Rule 144 by former officer and director Martin Bonick. The shares are held at Fidelity Brokerage Services LLC. The notice lists a proposed sale on the NYSE on 08/18/2026.

The securities to be sold relate to restricted stock vesting awards from the issuer, including 19,990 shares vesting on 03/31/2025 and 15,940 shares vesting on 03/31/2026, both described as compensation. Fidelity signed the notice as attorney-in-fact for Bonick.

Key Figures

Shares held in brokerage account: 35,930 shares Indicated value of held shares: $393,481.70 Shares from 03/31/2025 restricted stock vesting: 19,990 shares +2 more

5 metrics

Shares held in brokerage account 35,930 shares Ardent Health, Inc. common stock position at Fidelity Brokerage Services LLC

Indicated value of held shares $393,481.70 Approximate value of 35,930 Ardent Health, Inc. shares

Shares from 03/31/2025 restricted stock vesting 19,990 shares Common stock awarded as compensation vesting on 03/31/2025

Shares from 03/31/2026 restricted stock vesting 15,940 shares Common stock awarded as compensation vesting on 03/31/2026

Proposed sale date 08/18/2026 Potential sale of Ardent Health, Inc. common stock on NYSE

Key Terms

Rule 144, Restricted Stock Vesting, attorney-in-fact, compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Vesting financial

"Common | 03/31/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

compensation financial

"15940 | 03/31/2026 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing mean for Ardent Health, Inc. (ARDT)?

The filing reports a planned resale of Ardent Health, Inc. common stock under Rule 144 by former officer and director Martin Bonick. It is a regulatory notice of potential sales, not a new issuance of shares by the company.

Who is selling Ardent Health, Inc. (ARDT) shares in this Form 144?

The Form 144 lists Martin Bonick, a former officer and director of Ardent Health, Inc., as the person for whose account the securities may be sold. Fidelity Brokerage Services LLC acts as the broker and attorney-in-fact for this sale notice.

How many Ardent Health, Inc. (ARDT) shares are related to restricted stock vesting?

The notice identifies 19,990 shares of common stock from restricted stock vesting on 03/31/2025 and 15,940 shares from restricted stock vesting on 03/31/2026. Both tranches are described as compensation from the issuer.

What is the reported current holding for the Ardent Health, Inc. (ARDT) account?

The Form 144 lists 35,930 shares of Ardent Health, Inc. common stock in the Fidelity Brokerage Services LLC account, with an indicated value of $393,481.70. This figure provides context for the size of the potential sales.

When are the Ardent Health, Inc. (ARDT) shares expected to be sold?

The filing indicates a proposed sale date of 08/18/2026 on the NYSE for the common stock held. Form 144 notices outline potential sales and do not guarantee that all listed shares will actually be sold.

What is the source of the Ardent Health, Inc. (ARDT) shares to be sold?

The shares identified for sale come from restricted stock vesting awards granted by Ardent Health, Inc. to Martin Bonick. The filing describes these awards as compensation from the issuer, vesting on specific future dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:11 PM EDT Accepted by SEC EDGAR 08/18/2026 - 04:11 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001598595
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ardent Health, Inc.
SEC File Number	001-42180
Address of Issuer	340 SEVEN SPRINGS WAY SUITE 100 BRENTWOOD TENNESSEE 37027
Phone	6152963000
Name of Person for Whose Account the Securities are To Be Sold	Bonick Martin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer & Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	35930	393481.70	141045907	08/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/31/2025	Restricted Stock Vesting	Issuer			19990	03/31/2025	Compensation
Common	03/31/2026	Restricted Stock Vesting	Issuer			15940	03/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Martin Bonick
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)